Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/30/2003US6670469 Method for producing regular porous cellulose pearls, corresponding cellulose pearls and use thereof
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670401 Polysubstituted indan-1-ol compounds, and methods for their preparation and use
12/30/2003US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide;
12/30/2003US6670399 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited
12/30/2003US6670398 Compounds and methods for treating transplant rejection
12/30/2003US6670397 Needed for regenerating organs or body parts, following cellular degeneration, injury or amputation; also for treating cancer and autoimmune disease; dedifferentiating cells then stabilization
12/30/2003US6670396 Aspirin-triggered lipid mediators
12/30/2003US6670395 Phenoxyacetic acid and/or a lower alkyl ester thereof
12/30/2003US6670394 Method for treating COPD
12/30/2003US6670392 Administering vitamin e and selenium, or compound thereof
12/30/2003US6670391 For inhibiting both immediate and delayed type allergic reactions; side effect reduction
12/30/2003US6670390 Polyphenols and procyanidins; increasing nitric oxide synthesis
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670387 Thrombocytopenia; hydroxy-1-azo-naphthalene derivatives; 3-hydroxy-4-((2-hydroxy-1-naphthalenyl)azo-)-1-naphthalenesul fonic acid; promoters of thrombopoiesis and megakaryocytopoi esis; enhancing platelet production; agonizing TPO receptor
12/30/2003US6670384 Methods of administering epothilone analogs for the treatment of cancer
12/30/2003US6670383 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity
12/30/2003US6670381 Benzamide derivatives as thrombin inhibitors
12/30/2003US6670380 Pyridone inhibitors of fatty acid binding protein and method
12/30/2003US6670379 Piperidine compounds for use as ccr-3 inhibitors
12/30/2003US6670378 Method of treating Parkinson's disease
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670374 Enteric bacterial pathogens, including Shigella species, enterohemorrhagic E. coli, and enterotoxigenic E. coli; inhibit Golgi mannosidase II activity
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670370 Cough suppression; reacting dextromethorphan with tannic acid
12/30/2003US6670369 Use of phanquinone for the treatment of alzheimer's disease
12/30/2003US6670368 Pyrimidine compounds with pharmaceutical activity
12/30/2003US6670367 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists
12/30/2003US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/30/2003US6670365 Substituted imidazo 1,2a}azines as selective inhibitors of cox-2
12/30/2003US6670364 Antagonists of MCP-1 function and methods of use thereof
12/30/2003US6670361 Anticancer agents
12/30/2003US6670360 Antiulcer, antibacterial activity against Helicobacter pylori
12/30/2003US6670359 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders
12/30/2003US6670358 Substituted thioacetamides
12/30/2003US6670356 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
12/30/2003US6670355 Rapamycin
12/30/2003US6670354 Methods to enhance white blood cell count
12/30/2003US6670353 Oxime-group containing oestrone sulphatase inhibitors
12/30/2003US6670352 Androgenic steroid compounds and a method of making and using the same
12/30/2003US6670351 Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
12/30/2003US6670350 Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same
12/30/2003US6670349 Asthma
12/30/2003US6670348 Antitumor geldanamycins
12/30/2003US6670346 Treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans, administering selective estrogen
12/30/2003US6670343 Methanebisphosphonic acid derivative, or a hydrate
12/30/2003US6670342 Method of treating hepatitis delta virus infection
12/30/2003US6670341 Phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone
12/30/2003US6670340 6-Mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block
12/30/2003US6670339 Use of sulfated oligosaccharides in lowering blood triglyceride levels
12/30/2003US6670338 Pentasaccharides processes for their preparation and pharmaceutical compositions containing them
12/30/2003US6670337 Administering CM101, a generally nontoxic polysaccharide isolated from group B beta -hemolytic Streptococcus (GBS) bacteria, to minimize scarring and to accelerate wound healing
12/30/2003US6670336 Aryl phosphate derivatives of d4T having anti-HIV activity
12/30/2003US6670334 Antiinflammatory agent
12/30/2003US6670332 Cytofectins comprising complex amphiphilic lipids in which a bioactive agent which is recognized by biological systems is joined to a Rosenthal Inhibitor core structure through an alkyl linking group
12/30/2003US6670330 Cancer chemotherapy with 2-deoxy-D-glucose
12/30/2003US6670186 RNA-loaded antigen presenting cells
12/30/2003US6670183 88kDa tumorigenic growth factor and antagonists
12/30/2003US6670177 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus
12/30/2003US6670147 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
12/30/2003US6670146 Contacting a naive T cell with a stimulatory signal and an appropriate amount of a combination of Vitamin D3 and Dexamethasone, wherein contacting results in differentiation to a regulatory T cell
12/30/2003US6670138 Method of diagnosing ischemic stroke via UCP-2 detection
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6670118 Method for treating papillomavirus infections
12/30/2003US6669981 Light stabilized antimicrobial materials
12/30/2003US6669967 Method for the treatment of symptoms related to normal hormonal variations in women
12/30/2003US6669964 Composition for solubilizing salicylic acid
12/30/2003US6669958 Gel delivery vehicles for anticellular proliferative agents
12/30/2003US6669957 Solid pills/pharmaceutical comprising paracetamol or tramadol dispersed in diluents and vinyl acetate-vinylpyrrolidinone copolymer as excipients, to form tablets having good texture and taste
12/30/2003US6669955 Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
12/30/2003US6669953 Transdermal patches comprising pressure sensitive adhesives for delivery fo drugs such as isosorbide mononitrate, indomethacin or ketoprofen; sustained release
12/30/2003US6669952 Composition containing isoflavone material and plant sterol for reducing LDL-cholesterol
12/30/2003US6669948 Cefuroxime, cefpodoxime, amoxicillin and dioxacillin; first, second, and third dosage forms with different release profiles, reaching a Cmax in < twelve hours
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6669936 Gene therapy
12/30/2003US6669935 Transducing endothelial cells of arteries in brain, with genetic vectors including polynucleotides which code for cytolysis drugs; gene therapy; drug delivery
12/30/2003US6669926 Hydrophilic light absorbing indole compounds for determination of physiological function in critically ill patients
12/30/2003US6669903 Celluose acetate coating for sterilization of Trichophyton (fungi), and enteropathogenic Escherichia coli or methicillin tolerant Staphylococcus aureus
12/30/2003US6669623 One-shelled or multi-shelled nanoscalar particles composed of a core containing iron oxide and of an inner shell with groups capable of forming cationic groups which generates heat when alternating electromagnetic field applied
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/30/2003CA2346001C Controlled release nanoparticulate compositions
12/30/2003CA2338325C Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
12/30/2003CA2301086C Animal feed containing carboxylic acids
12/30/2003CA2293621C 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists
12/30/2003CA2291931C Isochroman compounds and their production process
12/30/2003CA2291732C A salt (r)-3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxaminde hydrogen (2r,3r)-tartrate
12/30/2003CA2288977C Use of diphosphonic acids or the physiologically acceptable salts or esters thereof in the preventive treatment of after-effects resulting from enlargement or replacement of the bladder
12/30/2003CA2273960C Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
12/30/2003CA2269474C Method of alleviating pain by means of combining tramadol with an nmda antagonist
12/30/2003CA2266015C Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
12/30/2003CA2263563C Cyclopentenones, process for preparing the same, and the use thereof
12/30/2003CA2241923C Receptor-mediated gene transfer system for targeting tumor gene therapy
12/30/2003CA2224663C Animal feed compositions and uses of triterpenoid saponin obtained from camellia l. plants
12/30/2003CA2221356C Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
12/30/2003CA2164638C Novel erythromycin derivatives, method for preparing same and use thereof as drugs
12/30/2003CA2163791C Anti-infective materials
12/30/2003CA2158331C Injection vessel and solution-enclosed injection vessel in use thereof
12/30/2003CA2148617C System for dispensing pharmaceutically active compounds
12/30/2003CA2146723C Percutaneous absorption preparation
1 ... 5230 5231 5232 5233 5234 5235 5236 5237 5238 5239 5240 5241 5242 5243 5244 5245 5246 5247 5248 5249 5250 ... 7860